| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.3 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.051 | 0.3 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.32 | 0.3 |